Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): A shared model for pathogenesis?

Inflammatory Bowel Diseases

Volumn 16, Issue 3, 2010, Pages 361-

  Sidhu, Reena ^a   Drew, Kaye ^a   McAlindon, Mark E ^a   Lobo, Alan J ^a   Sanders, David S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A; GASTROINTESTINAL HORMONE;

CELL DIVISION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; ENTERITIS; ENTEROCHROMAFFIN CELL; HUMAN; HYPERPLASIA; IRRITABLE COLON; LETTER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

CHROMOGRANIN A; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME;

EID: 77149147181     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20982     Document Type: Letter

References (3)

1. Sciola V, Massironi S, Conte D, et al. Plasma chromogranin A in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008 (in press).
2. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770-1798.
3. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in post-infectious IBS. Gastroenterology. 2003;125: 1651-1659.